Himelstein, Andrew L <br/><br/>
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.  [electronic resource] 

 -  JAMA  01 2017 
 - 48-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.2016.19425  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Neoplasms--secondary<br/>Bone and Bones--radiation effects<br/>Breast Neoplasms--pathology<br/>Diphosphonates--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Imidazoles--administration & dosage<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--pathology<br/>Pain Measurement<br/>Prostatic Neoplasms--pathology<br/>Sample Size<br/>Spinal Cord Compression--surgery<br/>Spinal Fractures--surgery<br/>Zoledronic Acid